"Carcinoma, Basal Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
Descriptor ID |
D002280
|
MeSH Number(s) |
C04.557.470.200.165 C04.557.470.565.165
|
Concept/Terms |
Carcinoma, Basal Cell- Carcinoma, Basal Cell
- Basal Cell Carcinoma
- Basal Cell Carcinomas
- Carcinomas, Basal Cell
- Rodent Ulcer
- Rodent Ulcers
- Ulcers, Rodent
- Ulcer, Rodent
- Epithelioma, Basal Cell
- Basal Cell Epithelioma
- Basal Cell Epitheliomas
- Epitheliomas, Basal Cell
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Basal Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Basal Cell".
This graph shows the total number of publications written about "Carcinoma, Basal Cell" by people in this website by year, and whether "Carcinoma, Basal Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 2 | 0 | 2 |
2000 | 2 | 0 | 2 |
2001 | 2 | 0 | 2 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2005 | 2 | 1 | 3 |
2006 | 0 | 2 | 2 |
2007 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2009 | 3 | 0 | 3 |
2011 | 3 | 1 | 4 |
2012 | 4 | 0 | 4 |
2013 | 4 | 0 | 4 |
2014 | 6 | 0 | 6 |
2016 | 4 | 0 | 4 |
2017 | 2 | 0 | 2 |
2018 | 3 | 0 | 3 |
2020 | 0 | 3 | 3 |
2021 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Basal Cell" by people in Profiles.
-
Neale H, Michelon M, Jacob S, Pinkston M, Ukaegbu R, Zamor W, Morrison E, Deng A, Levin NA. Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis. J Am Acad Dermatol. 2022 08; 87(2):423-425.
-
Baltz JO, Jellinek NJ. Delayed Facial Nerve Palsy After Mohs Surgery. Dermatol Surg. 2021 08 01; 47(8):1112-1113.
-
Mulvaney PM, Piris A, Besaw RJ, Schmults CD. Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer. Dermatol Surg. 2021 02 01; 47(2):194-199.
-
Baltz JO, Jellinek NJ. Reconstruction of a Defect Involving the Cupid's Bow. Dermatol Surg. 2020 12; 46(12):1733-1735.
-
Daniel VT, Mahmoud BH. Reconstruction of a Large Glabellar Defect. Dermatol Surg. 2020 11; 46(11):1437-1439.
-
Yaroslavsky AN, Feng X, Yu SH, Jermain PR, Iorizzo TW, Neel VA. Dual-Wavelength Optical Polarization Imaging for Detecting Skin Cancer Margins. J Invest Dermatol. 2020 10; 140(10):1994-2000.e1.
-
Ozcan U, Akyurek M, Arslan E. Complex Scalp and Calvarium Defects After Giant Basal Cell Carcinoma Excision: Management, Challanges, Outcomes. J Craniofac Surg. 2018 Jul; 29(5):1273-1275.
-
Rohani P, Yaroslavsky AN, Feng X, Jermain P, Shaath T, Neel VA. Collagen disruption as a marker for basal cell carcinoma in presurgical margin detection. Lasers Surg Med. 2018 09; 50(9):902-907.
-
Svoboda RM, Gharia MJ, Shell J, Gregory WD. Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications. J Am Acad Dermatol. 2018 Sep; 79(3):591-593.
-
Yaroslavsky AN, Feng X, Neel VA. Optical mapping of nonmelanoma skin Cancers-A pilot clinical study. Lasers Surg Med. 2017 11; 49(9):803-809.